209 related articles for article (PubMed ID: 22681933)
1. Dominant-negative effect of truncated mannose 6-phosphate/insulin-like growth factor II receptor species in cancer.
Kreiling JL; Montgomery MA; Wheeler JR; Kopanic JL; Connelly CM; Zavorka ME; Allison JL; Macdonald RG
FEBS J; 2012 Aug; 279(15):2695-713. PubMed ID: 22681933
[TBL] [Abstract][Full Text] [Related]
2. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.
Zavorka ME; Connelly CM; Grosely R; MacDonald RG
Oncotarget; 2016 Sep; 7(38):62386-62410. PubMed ID: 27694692
[TBL] [Abstract][Full Text] [Related]
4. Domain interactions of the mannose 6-phosphate/insulin-like growth factor II receptor.
Kreiling JL; Byrd JC; MacDonald RG
J Biol Chem; 2005 Jun; 280(22):21067-77. PubMed ID: 15799974
[TBL] [Abstract][Full Text] [Related]
5. The mannose 6-phosphate-binding sites of M6P/IGF2R determine its capacity to suppress matrix invasion by squamous cell carcinoma cells.
Probst OC; Karayel E; Schida N; Nimmerfall E; Hehenberger E; Puxbaum V; Mach L
Biochem J; 2013 Apr; 451(1):91-9. PubMed ID: 23347038
[TBL] [Abstract][Full Text] [Related]
6. Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor.
Schiller HB; Szekeres A; Binder BR; Stockinger H; Leksa V
Mol Biol Cell; 2009 Feb; 20(3):745-56. PubMed ID: 19037107
[TBL] [Abstract][Full Text] [Related]
7. The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene.
Oates AJ; Schumaker LM; Jenkins SB; Pearce AA; DaCosta SA; Arun B; Ellis MJ
Breast Cancer Res Treat; 1998 Feb; 47(3):269-81. PubMed ID: 9516081
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells.
Chen Z; Ge Y; Landman N; Kang JX
BMC Cancer; 2002 Jul; 2():18. PubMed ID: 12149131
[TBL] [Abstract][Full Text] [Related]
9. M6P/IGF2R is mutated in squamous cell carcinoma of the lung.
Kong FM; Anscher MS; Washington MK; Killian JK; Jirtle RL
Oncogene; 2000 Mar; 19(12):1572-8. PubMed ID: 10734317
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth.
Rezgui D; Williams C; Savage SA; Prince SN; Zaccheo OJ; Jones EY; Crump MP; Hassan AB
J Mol Endocrinol; 2009 Apr; 42(4):341-56. PubMed ID: 19208780
[TBL] [Abstract][Full Text] [Related]
11. Dissecting mannose 6-phosphate-insulin-like growth factor 2 receptor complexes that control activation and uptake of plasminogen in cells.
Leksa V; Pfisterer K; Ondrovičová G; Binder B; Lakatošová S; Donner C; Schiller HB; Zwirzitz A; Mrvová K; Pevala V; Kutejová E; Stockinger H
J Biol Chem; 2012 Jun; 287(27):22450-62. PubMed ID: 22613725
[TBL] [Abstract][Full Text] [Related]
12. Binding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor: contrasting interactions of full-length and soluble forms of uPAR.
Kreiling JL; Byrd JC; Deisz RJ; Mizukami IF; Todd RF; MacDonald RG
J Biol Chem; 2003 Jun; 278(23):20628-37. PubMed ID: 12665524
[TBL] [Abstract][Full Text] [Related]
13. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity.
De Souza AT; Hankins GR; Washington MK; Orton TC; Jirtle RL
Nat Genet; 1995 Dec; 11(4):447-9. PubMed ID: 7493029
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
Xie S; Kang JX
Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the gene encoding the human mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in human cell lines resistant to growth inhibition by transforming growth factor beta(1) (TGF-beta(1)).
Gemma A; Hosoya Y; Uematsu K; Seike M; Kurimoto F; Yoshimura A; Shibuya M; Kudoh S
Lung Cancer; 2000 Nov; 30(2):91-8. PubMed ID: 11086202
[TBL] [Abstract][Full Text] [Related]
16. Genetic changes and expression of the mannose 6-phosphate/insulin-like growth factor II receptor gene in human hepatitis B virus-associated hepatocellular carcinoma.
Yang EB; Qin LL; Zhao YN; Zhang K; Chow P
Int J Mol Med; 2003 Jun; 11(6):773-8. PubMed ID: 12736721
[TBL] [Abstract][Full Text] [Related]
17. M6P/IGF2R modulates the invasiveness of liver cells via its capacity to bind mannose 6-phosphate residues.
Puxbaum V; Nimmerfall E; Bäuerl C; Taub N; Blaas PM; Wieser J; Mikula M; Mikulits W; Ng KM; Yeoh GC; Mach L
J Hepatol; 2012 Aug; 57(2):337-43. PubMed ID: 22521359
[TBL] [Abstract][Full Text] [Related]
18. The mannose 6-phosphate/insulin-like growth factor II receptor restricts the tumourigenicity and invasiveness of squamous cell carcinoma cells.
Probst OC; Puxbaum V; Svoboda B; Leksa V; Stockinger H; Mikula M; Mikulits W; Mach L
Int J Cancer; 2009 Jun; 124(11):2559-67. PubMed ID: 19195023
[TBL] [Abstract][Full Text] [Related]
19. Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids.
Kang JX; Bell J; Beard RL; Chandraratna RA
Cell Growth Differ; 1999 Aug; 10(8):591-600. PubMed ID: 10470859
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury.
Kong FM; Anscher MS; Sporn TA; Washington MK; Clough R; Barcellos-Hoff MH; Jirtle RL
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):35-41. PubMed ID: 11163495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]